View Item 

Show simple item record

Editorial: ultrasound surveillance of hepatocellular carcinoma in the 21st century – authors’ reply
dc.contributor.authorSimmons, O.
dc.contributor.authorFetzer, D. T.
dc.contributor.authorYokoo, T.
dc.contributor.authorMarrero, J. A.
dc.contributor.authorYopp, A.
dc.contributor.authorParikh, N.
dc.contributor.authorBrowning, T.
dc.contributor.authorSingal, A. G.
dc.date.accessioned2017-02-02T22:01:59Z
dc.date.available2018-04-02T18:03:23Zen
dc.date.issued2017-02
dc.identifier.citationSimmons, O.; Fetzer, D. T.; Yokoo, T.; Marrero, J. A.; Yopp, A.; Parikh, N.; Browning, T.; Singal, A. G. (2017). "Editorial: ultrasound surveillance of hepatocellular carcinoma in the 21st century – authors’ reply." Alimentary Pharmacology & Therapeutics (4): 562-563.
dc.identifier.issn0269-2813
dc.identifier.issn1365-2036
dc.identifier.urihttps://hdl.handle.net/2027.42/136042
dc.publisherWiley Periodicals, Inc.
dc.titleEditorial: ultrasound surveillance of hepatocellular carcinoma in the 21st century – authors’ reply
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOtolaryngology
dc.subject.hlbsecondlevelPharmacy and Pharmacology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/136042/1/apt13910.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/136042/2/apt13910_am.pdf
dc.identifier.doi10.1111/apt.13910
dc.identifier.sourceAlimentary Pharmacology & Therapeutics
dc.identifier.citedreferencePatel D. Editorial: ultrasound surveillance of hepatocellular carcinoma in the 21 st century. Aliment Pharmacol Ther 2017; 45: 561 – 2.
dc.identifier.citedreferenceBerhane S, Toyoda H, Tada T, et al. Role of the GALAD and BALAD‐2 serologic models in diagnosis of hepatocellular carcinoma and prediction of survival in patients. Clin Gastroenterol Hepatol 2016; 14: 875 – 86.
dc.identifier.citedreferenceSimmons O, Fetzer DT, Yokoo T, et al. Predictors of adequate ultrasound quality for HCC surveillance in patients with cirrhosis. Aliment Pharmacol Ther 2017; 45: 169 – 77.
dc.identifier.citedreferenceAtiq O, Tiro J, Yopp AC, et al. An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis. Hepatology 2016; doi: 10.1002/hep.28895 [Epub ahead of print].
dc.identifier.citedreferenceSingal AG, Conjeevaram HS, Volk ML, et al. Effectiveness of hepatocellular carcinomasurveillance in patients with cirrhosis.  Cancer Epidemiol Biomarkers Prev 2012; 21: 793 – 9.
dc.identifier.citedreferenceSingal A, Volk ML, Waljee A, et al. Meta‐analysis: surveillance with ultrasound for early‐stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther 2009; 30: 37 – 47.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
apt13910.pdf
Size:
73.30KB
Format:
PDF
View/Open
Name:
apt13910_am.pdf
Size:
43.76KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.